NDC 50090-0497

Novolin R

Human Insulin

Novolin R is a Subcutaneous Injection, Solution in the Human Otc Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Insulin Human.

• Product ID: 50090-0497_e4a93fc0-9785-4f8b-b9a8-6c080a310e7d
• NDC: 50090-0497
• Product Type: Human Otc Drug
• Proprietary Name: Novolin R
• Generic Name: Human Insulin
• Dosage Form: Injection, Solution
• Route of Administration: SUBCUTANEOUS
• Marketing Start Date: 1991-06-25
• Marketing Category: BLA / NDA
• Application Number: BLA019938
• Labeler Name: A-S Medication Solutions
• Substance Name: INSULIN HUMAN
• Active Ingredient Strength: 100 [iU]/mL
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 50090-0497-0

1 VIAL in 1 CARTON (50090-0497-0) > 10 mL in 1 VIAL

• Marketing Start Date: 2014-11-28
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 50090-0497-0 [50090049700]

Novolin R INJECTION, SOLUTION

• Marketing Category: NDA
• Application Number: NDA019938
• Product Type: HUMAN OTC DRUG
• Billing Unit: ML
• Marketing Start Date: 2014-11-28

Drug Details

Active Ingredients

Ingredient	Strength
INSULIN HUMAN	100 [iU]/mL

OpenFDA Data

• SPL SET ID: 11f9e71d-249d-4de5-be02-a6eb8bf373cd
• Manufacturer:
  • A-S Medication Solutions
• UNII:
  • 1Y17CTI5SR
• RxNorm Concept Unique ID - RxCUI:
  • 311033
  • 311034

NDC Crossover Matching brand name "Novolin R" or generic name "Human Insulin"

NDC	Brand Name	Generic Name
0169-1833	Novolin	Human Insulin
0169-1834	Novolin	Human Insulin
0169-1837	Novolin	Human Insulin
0169-3003	Novolin	Human Insulin
0169-3004	Novolin	Human Insulin
0169-3007	Novolin	Human Insulin
50090-0403	Novolin	Human Insulin
50090-0497	Novolin	Human Insulin
50090-0498	Novolin	Human Insulin
64725-1833	Novolin	Human Insulin
64725-1834	Novolin	Human Insulin
64725-1837	Novolin	Human Insulin
68071-1701	Novolin	Human Insulin